The macrolide antibiotic, erythromycin, has been shown to induce effects on gastrointestinal motor activity closely resembling those of the polypeptide motilin.'2 The facts that erythromycin displaces motilin bound to its receptor,34 induces contractions in the gastrointestinal tract through the same mechanism as motilin,35' and displays the same regional and species specificities as motilin,3 suggest that erythromycin acts as a motilin agonist.47 Moreover, the ability of erythromycin derivatives to displace motilin correlates with their ability to induce contractions,' and for one erythromycin derivative it has been shown in binding experiments that the interaction with motilin was a competitive one.4 As motilin receptors are abundant on the muscle cells of the human gastric antrum and the proximal duodenum,8 erythromycin and its derivatives may constitute a new group of agents, which could be of therapeutic value in patients with disordered gastroduodenal motor function. This is suggested also by preliminary results of studies in, albeit small, numbers ofpatients with such disorders. In abstract form, it has been reported that erythromycin enhanced gastric evacuation in 'many' of eight patients with delayed emptying after vagotomy and antrectomy9 and in four of five individuals with idiopathic or diabetic gastroparesis. '0 The results of a study published in full showed that, in patients with diabetic gastroparesis, erythromycin accelerated gastric emptying not only when administered as a single intravenous dose, but also when given orally over a four week period.
recorded scintigraphicaily for 90 minutes. In addition, plasma motilin and pancreatic polypeptide concentrations were determined. With placebo, antral contractions were of regular 3 cycles/minute frequency. With erythromycin, less frequent and partly arhythmic long duration contractions set in and emptying was accelerated: after 90 minutes, the activity remaining in the stomach was markedly less than with placebo in all patients (Sign test, p<0002). Basal motilin and pancreatic polypeptide concentrations were normal and showed a normal response to the meal in all patients. Motilin concentrations decreased slightly more and pancreatic polypeptide concentrations increased markedly more with erythromycin than with placebo, possibly because the meal reached the intestine earlier.
In conclusion, erythromycin accelerated emptying markedly and in most patients induced an antral motor activity characterised by long duration contractions occurring at often irregular intervals. (Gut 1993; 34: 166-172) The macrolide antibiotic, erythromycin, has been shown to induce effects on gastrointestinal motor activity closely resembling those of the polypeptide motilin.'2 The facts that erythromycin displaces motilin bound to its receptor,34 induces contractions in the gastrointestinal tract through the same mechanism as motilin,35' and displays the same regional and species specificities as motilin,3 suggest that erythromycin acts as a motilin agonist. 47 Moreover, the ability of erythromycin derivatives to displace motilin correlates with their ability to induce contractions,' and for one erythromycin derivative it has been shown in binding experiments that the interaction with motilin was a competitive one. 4 As motilin receptors are abundant on the muscle cells of the human gastric antrum and the proximal duodenum,8 erythromycin and its derivatives may constitute a new group of agents, which could be of therapeutic value in patients with disordered gastroduodenal motor function. This is suggested also by preliminary results of studies in, albeit small, numbers ofpatients with such disorders. In abstract form, it has been reported that erythromycin enhanced gastric evacuation in 'many' of eight patients with delayed emptying after vagotomy and antrectomy9 and in four of five individuals with idiopathic or diabetic gastroparesis. ' 0 The results of a study published in full showed that, in patients with diabetic gastroparesis, erythromycin accelerated gastric emptying not only when administered as a single intravenous dose, but also when given orally over a four week period. " The aim of the present study was to evaluate the effects of erythromycin on the impaired gastric motor function shown to prevail in patients with primary anorexia nervosa.'2 '7 In such patients, in whom the resumption ofnormal eating behaviour often is discouraged by the symptoms of gastric stasis, an acceleration of gastric emptying by erythromycin not only would provide further information on the potential prokinetic properties of the compound, but also be of major clinical importance. In addition, the study was aimed at evaluating the effects of erythromycin on the plasma concentrations of motilin and pancreatic polypeptide. On the basis of the three second frames, antral motility was evaluated employing a factor analytic method.2122 Using principal component analysis and varimax rotation, this method at first identifies orthogonal factors. A subsequent oblique transformation of the factors23 makes use of the fact that, within the area imaged by the gamma camera, regions can always be identified, in which no temporal changes of radioactivity occur. These regions are utilised as a baseline setting and permit the computation of the transformation matrix, which then is applied to the varimax factors. The results of the transformation are expressed as factor images and factor curves, the latter essentially reflecting the factor loadings. Factor images and factor curves represent the activity changes recorded over the antrum and thereby the underlying contractile activity. Each of the factor images delineates an area of uniform activity change, wherein the relative intensity in each pixel represents the contribution of that element to the total activity change. The associated factor curves depict the global variation of intensities over time. Appropriately scaled, the factor curves correspond closely to activity time curves generated for regions of interest drawn over the prominent areas of the factor images.24
Methods
All computational work was done on a graphical work station (SparcStation IPC, Sun Microsystems, Mountain View, CA, USA). The software package Analyze25 was used for the display of the scintigraphic images, and a version of a program package for factor analysis implemented in the programming language C+ + (ToddPokropek A and Samal M, unpublished work) for the factor analysis. As an input, the latter program requires, apart from the image sequence to be analysed, the region in which the moving structures are to be identified -that is, a region corresponding to the anatomical bounds of the antrum, and a background region as described above. The analysis was set to account for three factors, since previous studies have shown that three factors explain more than 95% of the total variance of a given study of antral motility. As a measure of the amplitude of antral contractions, the mean modulation depth of each factor curve was derived from the standard deviation of the mean excursion of the individual points on the curve. 6 9 Then the autocorrelation function ofthe curve was computed and used to determine the frequency of antral contractions.
The total body radiation burden ( Basal motilin concentrations ranged from 246 to 783 pg/ml (mean, 447-9 pg/ml (67 9) (SEM) before placebo administration and from 229 to 665 pg/ml (mean, 410-9 (57 8) pg/ml) before erythromycin. In all cases, motilin levels decreased gradually over the first 60 minutes after the start of the infusion. In the patients in whom motilin could be determined with both treatments, plasma concentrations decreased, on the mean, faster and more with erythromycin than with placebo (Fig 4) . The analysis showed that the effects of the two treatments differed statistically (F (1,7)=11 5, p<0O02) . The overall downwards trend of plasma concentrations resulted in a significant F value for the time factor (F (6,42)=10-56, p<0001). At 90 minutes, motilin levels were slightly higher than at 60 minutes in seven of the 10 patients having received erythromycin and in four of the eight patients, in whom motilin concentrations could be measured after placebo administraton.
Basal pancreatic polypeptide concentrations ranged from 29 pg/ml to 489 pg/ml (mean, 198 9 (54-4) pg/ml) before placebo administration and from 30 pg/ml to 382 pg/ml (mean, 152-5 pg/ml) before infusion of erythromycin. In all patients, pancreatic polypeptide concentrations increased sharply with meal ingestion, the increases being about as high in the patients in whom subsequently erythromycin was infused as in the ones who subsequently received placebo (Fig 5) . Immediately after placebo infusion, plasma concentrations were only slightly higher than before and peak levels occurred either at that time point or 10 -minutes later. After the infusion of erythromycin, however, plasma concentrations were markedly higher than before the infusion in all of the patients (Fig 5) . Thereafter, pancreatic polypeptide concentrations decreased again but remained on a higher level than after placebo throughout the recording time. The analysis showed that the treatment effects differed, although statistical significance was not 
Discussion
The results of the present study show that erythromycin markedly accelerated gastric emptying in all of the 10 patients with primary anorexia nervosa studied. This finding is consistent with observations made in patients with diabetic'0°" and idiopathic gastroparesis,'°and with impaired gastric motor function after vagotomy and antrectomy.9 Erythromycin markedly accelerated the delayed gastric emptying not only in relation to the emptying rate prevailing with placebo, but to such an extent that, in six of the 10 patients, t/2s were shorter than the 25th percentile of the tl/2s recorded in a group of 48 healthy individuals using the same recording technique and the same standard meal. A similar observation has been made by Janssens et all': in patients with diabetic gastroparesis having received erythromycin, the emptying of solid meal constituents was more rapid than in healthy untreated volunteers.
The enhanced emptying during and after erythromycin administration was associated, in the period nine to 10 minutes from the end of meal ingestion, with strong antral contractions of long duration. In contrast with the entirely rhythmic antral activity occurring at a frequency of about three cycles/minute during and after the infusion of placebo, these contractions were of lower and often irregular frequency. The induction by intravenous erythromycin of forceful antral contractions has also been reported by other authors, who had observed this phenomenon to occur not only in the postprandial period,32 33 study36 possibly is because the cutaneously recorded electrogastrogram reflects the slow wave activity only and not the superimposed spiking activity and thus can give no, and be it indirect, information on the contractions of the antrum.
Whether the accelerating effect of erythromycin on gastric emptying has to be attributed primarily to the induction of forceful antral contractions or to an effect on gastric tone, cannot be answered from the results of the present study. The strength of antral contractions, however, seems to play an important role. In healthy subjects, the emptying of solid, but not ofliquid, meal constituents has been found to be slow with low antral motor activity and faster with a more active antrum. 39 Similarly, in patients with gastric stasis, a slow emptying rate for solids was found to be associated with antral hypomotility." In a previous study in which the effects of the gastroprokinetic agent, cisapride, were evaluated in patients with primary anorexia nervosa and in which the same semisolid meal and the same recording technique was used as in the present investigation, the rate of emptying was related significantly to the amplitude of antral contractions. 16 The fall in motilin concentrations under both experimental conditions could be related mainly to an increase in blood glucose levels, as it has been reported41 that plasma motilin declined significantly after both the ingestion and the intravenous infusion of glucose. Such a mechanism would explain the fact that the plasma concentrations of motilin decreased more and earlier when erythromycin was administered: in this condition gastric emptying was faster than with placebo thus enabling an earlier absorption of the meal constituents in the small intestine. A direct effect of erythromycin on plasma motilin levels cannot be ruled out although it has been observed that erythromycin had no such effect in fasting humans.2 In fasted dogs, erythromycin induced a motilin release. ' Plasma pancreatic polypeptide concentrations under basal conditions were within the normal range in all patients and in all experimental sessions and also exhibited the normally occurring sharp increase after meal intake. In 
